-
Emerging Markets' Pharmaceutical Manufacturing Landscape: Shaping The Future In 2025
25 Apr 2025 18:02 GMT
… organizations (CDMOs) and pharmaceutical companies for countries in … Pvt Ltd Laviana Pharma Co Ltd Shenzhen Hepalink Pharmaceutical Group Wuhu Nuowei … Chemistry Co Ltd Zhejiang Huahai Pharmaceutical …
-
Robust Growth in Biological Drug CDMO Market (2024-2032): Industry Insights, SWOT Analysis, Market Size and Share
27 Nov 2024 11:31 GMT
… ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ:
The Biological Drug CDMO (Contract Development … Hepalink,Pharmaron
Market Split by Types:
โข Innovative Drug
โข Listed Patent Drugs … Biological Drug Contract … ๐๐ซ๐ฎ๐ ๐๐๐๐ ๐๐๐ซ๐ค๐๐ญ:
The Biological Drug CDMO (Contract Development and …
-
Primary Biliary Cholangitis Market Competition Analysis 2025: How Players Are Shaping Growth
02 Jan 2026 01:15 GMT
… Pharmaceuticals, Inc., Shenzhen Hepalink Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Zhongshan Pharmaceutical … U.S. Food and Drug Administration (FDA) approval ( … ?
โขFocusing on orphan drug designations to enhance therapeutic …
-
Hong Kong police investigate email scam following German pharmaceutical firmโs report it was swindled out of more than RM15.34mil
16 Jan 2024 07:57 GMT
… involved Hong Kong. Separately, the Shenzhen Hepalink Pharmaceutical Group, listed in Hong Kong … its wholly owned subsidiary โ Techdow Pharma Italy โ was suspected to have … about โฌ11.7mil (RM59.83mil). โ[Shenzhen Hepalink] promptly reported the incident to …
-
Hong Kong police investigate email scam following German pharmaceutical firmโs report it was swindled out of more than โฌ3 million
16 Jan 2024 02:08 GMT
… involved Hong Kong.
Separately, the Shenzhen Hepalink Pharmaceutical Group, listed in Hong Kong … its wholly owned subsidiary โ Techdow Pharma Italy โ was suspected to have … involved about โฌ11.7 million.
โ[Shenzhen Hepalink] promptly reported the incident to …
-
Shenzhen Hepalink Pharmaceutical Group (OTCMKTS:SHEZF) Downgraded by The Goldman Sachs Group to Sell
05 Oct 2023 14:07 GMT
…
Shenzhen Hepalink Pharmaceutical Group Stock Performance
Shenzhen Hepalink Pharmaceutical Group Company Profile
(Get Free Report)
Shenzhen Hepalink Pharmaceutical … analysts' ratings for Shenzhen Hepalink Pharmaceutical Group and related companies with …
-
Growing Emphasis on Generic Drug Manufacturing Boosts Active Pharmaceutical Ingredient Market to US$ 300.2 Billion by 2033: Persistence Market Research
25 Jul 2023 18:33 GMT
… and advancements in drug development technologies have been … Rising adoption of generic drugs and biosimilars.
Technological … Rising concerns over counterfeit drugs.
Market Trends
Increased … Roche Ltd, GlaxoSmithKline plc, Hepalink Group Lonza, Merck …
-
Global Active Pharmaceutical Ingredients Market Outlook & Forecast 2023-2028 - ResearchAndMarkets.com
25 Jul 2023 10:16 GMT
… other brand-name drugs. Moreover, generic drugs are often the … generic drug supply chain.
COMPETITIVE LANDSCAPE
The active pharmaceutical ingredients … -La Roche
GLENMARK PHARMACEUTICALS LTD.
Lupin
Shenzhen Hepalink Pharmaceutical Group
KEY QUESTIONS …
-
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab
28 Mar 2023 08:03 GMT
… ;), a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the … in 2003, OEP provides prescription drugs, cancer drugs, nutrition and healthcare for young …
-
Active Pharmaceutical Ingredients API Market Size, Share, Industry Outlook & Global Forecast To 2031
07 Jul 2022 11:26 GMT
… manufacturers
โข Type of drugs
โข Synthesis Type
ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTS
…
Market Segmentation by Type of drugs
โข Prescription
โข Over the … GmbH
โข BASF SE
โข Lupin
โข Shenzhen Hepalink Pharmaceutical Group Ltd.
โข Abbott
โข Biocon
โข …
About
© 1995-2026